Muscle Pharm Corp. (MSLP.OB) is one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, has been invited to present at the upcoming HIV DART(TM) 2010: Frontiers in Drug development for Antiretroviral Therapies Conference being held from December 7-10, 2010 in Los Cabos, Mexico.
At this year’s HIV DART(TM) 2010 Conference, MusclePharm will present its results on the use of its product, Recon, in HIV patients. Early results show that Recon may help prevent the onset of wasting syndrome by facilitating the growth and maintenance of muscle mass in people living with HIV, which has been associated with antiretroviral drug resistance.
MusclePharm’s President, Cory Gregory stated, “We started MusclePharm to enable people of all fitness levels to maintain and improve their general fitness through a daily nutritional supplement regimen. We are very pleased to have our work accepted by such a prestigious group of physicians and researchers focused on improving the lives of people with the HIV virus.”
Mr. Gregory continued, “This conference is well known for its prominent list of attendees, which includes the greatest minds HIV research has to offer. The fact that the scientific committee at HIV DART 2010 viewed our work as significant and ground breaking shows the scientific strength of our products and great promise for the future use of therapeutic nutritional supplements for the treatment of HIV disease.”
MusclePharm recently presented its findings on the use of Recon to prevent and treat wasting syndrome in HIV patients at XVIII International AIDS Conference this past July in Vienna, Austria at the Research Advances satellite symposium sponsored by the National Association of People with AIDS and The AIDS Institute. The Company also presented this past week at the 138th Annual Meeting of the American Public Health Association in Denver, CO.
For more information about this company please visit http://www.musclepharm.com
Eastman Kodak Co. (NYSE:EK) previously reported that Laura G. Quatela has been named the company’s General Counsel, effective Jan. 1, 2011, reporting to Chairman and Chief Executive Officer Antonio M. Perez.
Quatela, 53, is presently Kodak’s Chief Intellectual Property Officer, a member of the company’s Executive Council, and a corporate vice president. She will retain those responsibilities in tandem with her new duties leading the company’s Legal organization. The future structure of the IP organization will be announced at a later date.
As the world’s foremost imaging innovator, Kodak helps consumers, businesses, and creative professionals unleash the power of pictures and printing to enrich their lives.
SandRidge Energy, Inc. (NYSE:SD) announced that the initial purchasers of a previously announced private placement of the company’s 7.0% convertible perpetual preferred stock have exercised in full their option to purchase an additional 500,000 shares, bringing the size of the transaction to an aggregate of 3,000,000 shares. Aggregate net proceeds of the offering are expected to be approximately $290.5 million. As previously announced, the company intends to use the net proceeds from this offering for general corporate purposes, including (i) to repay a portion of the amount outstanding under its revolving credit facility and (ii) to fund the company’s capital expenditure program.
SandRidge Energy, Inc., together with its subsidiaries, operates as an independent natural gas and oil company in the United States. The company engages in the exploration, development, and production of oil and gas properties.
Flagstar Bancorp Inc. (NYSE:FBC) the holding company for Flagstar Bank, FSB, announced that it has completed its previously announced $400 million public equity offerings, comprised of 115.7 million shares of common stock and 14.2 million shares of convertible preferred stock and which includes 5.7 million shares of common stock and 0.7 million shares of preferred stock issued pursuant to the underwriters’ over-allotment option. The public equity offerings resulted in aggregate net proceeds of approximately $385.8 million, after deducting underwriting fees and estimated offering expenses. The convertible preferred stock is subject to automatic conversion upon the receipt of stockholder vote to authorize additional shares of common stock. The public offerings were underwritten solely by J.P. Morgan Securities LLC.
Flagstar Bancorp, with $13.8 billion in total assets, is the largest publicly held savings bank headquartered in the Midwest. At September 30, 2010, Flagstar operated 162 banking centers in Michigan, Indiana and Georgia and 27 home loan centers in 13 states. Flagstar Bank originates loans nationwide and is one of the leading originators of residential mortgage loans
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
PLEASE BE SURE TO VISIT CRWESELECT.NING.COM
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (MSLP.OB).